Profile
Donald J.
Kellerman formerly worked at Glaxo Wellcome, Inc., as Director-Respiratory Clinical Research, Ciba-Geigy Corp., as Vice President-Cardiovascular Products, Sumitomo Pharma America, Inc., as Vice President-Clinical Research from 1996 to 1997, Inspire Pharmaceuticals, Inc., as Senior Vice President-Development from 1999 to 2008, MAP Pharmaceuticals LLC, as Senior VP-Clinical Development & Medical Affairs from 2011 to 2013, E.
R.
Squibb & Sons LLC, as Vice President-Cardiovascular Products, Zosano Pharma Corp., as VP-Clinical Development & Medical Affairs from 2015 to 2022, and Tonix Pharmaceuticals Holding Corp., as SVP-Clinical Development & Regulatory Affairs from 2014 to 2015.
Dr. Kellerman received his undergraduate degree and doctorate degree from the University of Minnesota.
Former positions of Donald J. Kellerman
Companies | Position | End |
---|---|---|
ZOSANO PHARMA CORPORATION | Chief Tech/Sci/R&D Officer | 2022-05-31 |
TONIX PHARMACEUTICALS HOLDING CORP. | General Counsel | 2015-03-31 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Corporate Officer/Principal | 2008-07-20 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Chief Tech/Sci/R&D Officer | 1997-07-31 |
Training of Donald J. Kellerman
University of Minnesota | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
Private companies | 7 |
---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
E. R. Squibb & Sons LLC | |
Ciba-Geigy Corp. | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Zosano Pharma Corp.
Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Donald J. Kellerman